The Cardiovascular Business team embarked on this survey to gain a deeper understanding of the current state of cardiovascular health, the role CVIS plays and the goals cardiovascular leaders have established for the next few years. We polled readers of Cardiovascular Business magazine, CardiovascularBusiness.com and sister brand HealthExec.com over three months in the summer of 2019. All data is presented in aggregate, with individual responses remaining anonymous.
Some respondents shared deeper demographics that help us better get to know our survey base. Those 353 healthcare leaders work for 305 unique health systems, hospitals, physician groups, across 46 states and six Canadian provinces. They are large, small and mid-sized. Respondents came from all levels of leadership. Here are some of the titles of people who chimed in: CEO, CFO, CMO, CIO, chief of cardiology, chief population health officer, chief innovation officer, director of CV Lab, director of CV service line, director of heart and vascular institute, director of CV informatics, enterprise director of imaging, director of IT, system director for imaging and cardiology, head of data science and analytics and nurse managers in charge of STEMI, cath lab, structural heart and cardiac ICU.
Philips Healthcare is the sponsor of this survey but did not have a role in the data collection, tabulation or collation, thus maintaining the anonymity and integrity as promised to the survey base.
Read the report...
The 16-page report on the 2020 Cardiovascular Business Leadership Survey offers a snapshot of what health system and cardiovascular leaders think about priorities, challenges and trends. Some of it validates, while some enlightens. It all helps guide leadership on a data-rich and insightful journey into the future.